Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2
2024
How DNMT3B Affects Colorectal Cancer Growth
Sample size: 80
publication
Evidence: high
Author Information
Author(s): Ji Yong, Wang Yang, Zou Jiacheng, Liu Guanghao, Xia Mingyu, Ren Jun, Wang Daorong
Primary Institution: Yangzhou University
Hypothesis
DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2.
Conclusion
Overexpression of PLCG2 can inhibit the growth of colorectal cancer cells.
Supporting Evidence
- DNMT3B is overexpressed in colorectal cancer tissues compared to adjacent non-tumor tissues.
- High expression of DNMT3B correlates with poorer prognosis in colorectal cancer patients.
- PLCG2 is identified as a key downstream regulatory protein of DNMT3B in colorectal cancer.
- Overexpression of PLCG2 inhibits the proliferation of colorectal cancer cells.
Takeaway
This study found that a protein called DNMT3B helps colorectal cancer cells grow by stopping another protein, PLCG2, from working properly.
Methodology
The study used qRT-PCR, Western blot analysis, immunohistochemistry, and various assays to analyze cell proliferation and methylation levels.
Participant Demographics
Patients with colorectal cancer, no prior radiotherapy or chemotherapy.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website